
Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

Exploring both patient-level and organizational factors, researchers assess community pharmacy accessibility for immunizations and injectables.

In part 2, Neal Cooper and Matt Sample address the foreseeable challenges and necessary questions surrounding the FDA’s push toward 12-digit national drug codes.

Matt Sample and Neal Cooper join to discuss the beginning stages of the FDA’s 7-year rollout of new NDCs for prescription drugs.

This episode explores the gaps between pharmacy leaders and the communities, and patients, that they serve.

With workforce and work-life balance issues plaguing pharmacy, the newly introduced hybrid pharmacist role is creating innovation across the greater pharmacy industry.

In part 2 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explored the modernization behind his organization’s newly introduced ‘hybrid pharmacist’ role.

Rick Gates, chief pharmacy officer at Walgreens, helps introduce his organization’s innovative new ‘hybrid pharmacist’ role.

Benjamin Jolley, PharmD, presents on recent developments regarding pharmacy benefit manager reform on the state and federal levels.

TrumpRx offers discounted cash drug prices like a coupon card but skips PBM reform and raises concerns about deductible gaps and added pressure on independent pharmacies.

Travis Wolff, PharmD, BCACP, presents on the current landscape of medical billing in pharmacy practice and the steps pharmacists can take to realize a significantly higher profit margin.

Independent pharmacies boost retention with clear hiring expectations, structured onboarding, weekly check-ins, and real growth opportunities.

This issue discusses independent pharmacies retaining talent, navigating TrumpRx and MFN drug pricing shifts, and confronting pharmacy benefit manager power to protect community care.

Jon Grice, PharmD, MSA, vice president of pharmacy insights at Outcomes, explores the framework necessary and steps businesses must take to ensure pharmacy growth.

Event moderator Jesse McCullough, PharmD, wraps up the Total Pharmacy Solutions Summit Spring 2026 event with key takeaways and insights into the evolving road pharmacy is headed on.

Blair Thielemier, PharmD, EQUIPP customer success manager at PQS by Innovaccer, offers insight into key technology being used to realize greater revenue for pharmacy businesses.

Timothy Aungst, PharmD, and Ravi Patel, PharmD, MBA, MS, unpack the role of direct-to-patient in the current pharmacy landscape.

The question facing many independents is no longer whether vaccines matter but whether a vaccine program is truly right for their pharmacy.

Ketan Mehta, CEO and president of PrimeRx, presented a keynote session on helping independent pharmacies diversify purchasing, improve cash flow, and reduce the cost of goods sold.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Emily Hoffins, MS, PhD, postdoctoral researcher in the SCRPTS Lab at the University of Illinois Chicago Retzky College of Pharmacy.

This episode highlights the landmark FTC settlement with Express Scripts and what independent pharmacies and plan sponsors can expect going forward.

In Texas community pharmacies, researchers assess the communication concordance between pharmacists and patients during medication counseling.


Many states are pushing pharmacies to move beyond the traditional dispensing role into more robust clinical care.

From proposed transparency rules to Medicare price negotiation programs, the stakes are high for pharmacy reimbursement and the sustainability of independent practices.

From patient perspectives on acceptability, researchers assess the impact of pharmacist-led point-of-care testing services in rural Tennessee communities.

Amid increased use of artificial intelligence across pharmacy, researchers assess pharmacists’ propensity to trust the emerging automated technology.